Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001581351 | SCV001812089 | likely benign | not provided | 2021-02-18 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002072299 | SCV002472223 | likely benign | Aortic aneurysm, familial thoracic 7 | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002334623 | SCV002643504 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2020-03-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV002334623 | SCV003837874 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2022-01-13 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003987882 | SCV004804295 | benign | not specified | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003966227 | SCV004779229 | likely benign | MYLK-related disorder | 2021-06-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |